P/E at 60.75 vs Industry's 66.64: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Discount Amidst Sector Premiums

Apollo Hospitals Enterprise Ltd. trades at a P/E multiple of 60.75, which is approximately 8.8% below the hospital industry’s average P/E of 66.64. This discount is intriguing given the company’s stature as a large-cap with a market capitalisation of ₹1,27,371.64 crores. The valuation gap suggests that the market is pricing in either a more conservative growth outlook or risk factors relative to peers. However, the premium valuations typical of the hospital sector reflect expectations of steady demand and resilient earnings, especially in a post-pandemic environment. The discount raises the question of whether Apollo Hospitals is being undervalued or if the sector’s lofty multiples are justified by superior fundamentals elsewhere — previously rated Buy, what is Apollo Hospitals’ current rating?

Performance Across Timeframes: Strong Long-Term Gains, Mixed Recent Momentum

Examining returns over various periods reveals a compelling divergence. Over the past year, Apollo Hospitals has delivered an 18.05% gain, significantly outperforming the Sensex’s 9.47% loss. Year-to-date, the stock’s 25.78% rise further underscores its resilience amid broader market weakness, where the Sensex is down 14.57%. Extending the horizon, the three-year return of 76.25% and five-year return of 100.79% highlight the company’s sustained growth trajectory, far surpassing the Sensex’s 11.14% and 22.02% respectively. Even over a decade, the stock’s 547.43% appreciation dwarfs the Sensex’s 157.34% gain, reflecting a long-term compounding advantage.

However, the short-term momentum is less robust. The stock has declined 0.35% in the last trading session, outperforming the Sensex’s 1.47% fall but still marking a third consecutive day of losses, accumulating a 2.32% drop over this period. Over one week, the stock is down 0.91%, again outperforming the Sensex’s 2.74% decline. The one-month and three-month returns are modestly positive at 0.14% and 3.09% respectively, contrasting with the sector’s sharper declines. This pattern suggests a recent cooling off after a strong run, raising the question of whether this is a temporary pause or a more significant shift — is this a genuine recovery or a relief rally that will fade at the 50 DMA?

Moving Average Configuration: Mixed Signals from Technicals

The technical setup for Apollo Hospitals reveals a nuanced picture. The stock currently trades above its 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally positive medium to long-term trend. However, it remains below its 5-day moving average, signalling some short-term weakness or consolidation. This configuration often points to a recent pullback within an overall uptrend, suggesting that the stock may be undergoing a pause or minor correction before potentially resuming its advance. The interplay between short and long-term averages is critical for interpreting momentum shifts — is this a recovery or a dead-cat bounce?

Sector Context: Hospital Industry Performance

The hospital sector has experienced mixed results recently, with some companies facing headwinds from regulatory changes and cost pressures, while others benefit from rising healthcare demand. Within this environment, Apollo Hospitals stands out with its relative outperformance. The sector’s average P/E of 66.64 reflects elevated expectations, yet Apollo Hospitals trades at a discount to this multiple, suggesting a more cautious valuation stance by investors. Sector results have been varied, with some companies posting positive earnings surprises while others have struggled to maintain margins. This mixed backdrop adds complexity to the valuation and performance analysis of Apollo Hospitals, highlighting the importance of company-specific factors in driving returns.

Rating Context: Previously Rated Buy, Now Reassessed

On 23 Sep 2026, the rating for Apollo Hospitals Enterprise Ltd. was updated from Buy to a new assessment. While the current rating is not disclosed, the change reflects a reassessment of the company’s fundamentals, valuation, and technical outlook. The previous Mojo Score of 84.0 and the Buy rating indicated strong confidence in the company’s prospects. The updated rating likely incorporates the recent performance data, valuation discount relative to the sector, and the mixed technical signals. This reassessment invites investors to consider how these factors interplay — should investors in Apollo Hospitals hold, buy more, or reconsider?

Conclusion: A Complex Valuation and Performance Landscape

The data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a meaningful discount to its sector’s P/E multiple, despite delivering strong long-term returns. The recent short-term momentum shows some softness, reflected in the three-day losing streak and the stock’s position below its 5-day moving average, even as it remains above longer-term moving averages. This suggests a potential pause or consolidation within an overall positive trend. The sector’s mixed performance and the updated rating from previously Buy to a new assessment further complicate the outlook. Collectively, these factors highlight the importance of weighing valuation, performance, and technical signals in tandem — what is the current rating for Apollo Hospitals Enterprise Ltd.?

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today